» Articles » PMID: 37726805

Application of Mesenchymal Stem Cells for Anti-senescence and Clinical Challenges

Overview
Publisher Biomed Central
Date 2023 Sep 19
PMID 37726805
Authors
Affiliations
Soon will be listed here.
Abstract

Senescence is a hot topic nowadays, which shows the accumulation of senescent cells and inflammatory factors, leading to the occurrence of various senescence-related diseases. Although some methods have been identified to partly delay senescence, such as strengthening exercise, restricting diet, and some drugs, these only slow down the process of senescence and cannot fundamentally delay or even reverse senescence. Stem cell-based therapy is expected to be a potential effective way to alleviate or cure senescence-related disorders in the coming future. Mesenchymal stromal cells (MSCs) are the most widely used cell type in treating various diseases due to their potentials of self-replication and multidirectional differentiation, paracrine action, and immunoregulatory effects. Some biological characteristics of MSCs can be well targeted at the pathological features of aging. Therefore, MSC-based therapy is also a promising strategy to combat senescence-related diseases. Here we review the recent progresses of MSC-based therapies in the research of age-related diseases and the challenges in clinical application, proving further insight and reference for broad application prospects of MSCs in effectively combating senesce in the future.

Citing Articles

Unveiling distinctions between mesenchymal stromal cells and stem cells by single-cell transcriptomic analysis.

Yan K, Ma F, Song X, Wang H, Liu P, Zhang J Heliyon. 2025; 11(4):e42311.

PMID: 40034318 PMC: 11872483. DOI: 10.1016/j.heliyon.2025.e42311.


Engineering mesenchymal stem cells for premature ovarian failure: overcoming challenges and innovating therapeutic strategies.

Yuan Z, Zhang Y, He X, Wang X, Wang X, Ren S Theranostics. 2024; 14(17):6487-6515.

PMID: 39479455 PMC: 11519806. DOI: 10.7150/thno.102641.


Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction.

Xu C, Xie Y, Wang B Stem Cell Res Ther. 2024; 15(1):323.

PMID: 39334266 PMC: 11438184. DOI: 10.1186/s13287-024-03942-7.


Emerging Landscape of Mesenchymal Stem Cell Senescence Mechanisms and Implications on Therapeutic Strategies.

Wang J, Zhang M, Wang H ACS Pharmacol Transl Sci. 2024; 7(8):2306-2325.

PMID: 39144566 PMC: 11320744. DOI: 10.1021/acsptsci.4c00284.

References
1.
Gunawardena T, Masoudian Z, Rahman M, Ramasamy T, Ramanathan A, Abu Kasim N . Dental derived stem cell conditioned media for hair growth stimulation. PLoS One. 2019; 14(5):e0216003. PMC: 6493760. DOI: 10.1371/journal.pone.0216003. View

2.
Sikora E, Czarnecka-Herok J, Bojko A, Sunderland P . Therapy-induced polyploidization and senescence: Coincidence or interconnection?. Semin Cancer Biol. 2020; 81:83-95. DOI: 10.1016/j.semcancer.2020.11.015. View

3.
Wang L, Abhange K, Wen Y, Chen Y, Xue F, Wang G . Preparation of Engineered Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells with Ultrasonication for Skin Rejuvenation. ACS Omega. 2020; 4(27):22638-22645. PMC: 6941387. DOI: 10.1021/acsomega.9b03561. View

4.
Zhang C, Li Y, Qin J, Yu C, Ma G, Chen H . TMT-Based Quantitative Proteomic Analysis Reveals the Effect of Bone Marrow Derived Mesenchymal Stem Cell on Hair Follicle Regeneration. Front Pharmacol. 2021; 12:658040. PMC: 8237093. DOI: 10.3389/fphar.2021.658040. View

5.
Jensen L, Monnat S, Green J, Hunter L, Sliwinski M . Rural Population Health and Aging: Toward a Multilevel and Multidimensional Research Agenda for the 2020s. Am J Public Health. 2020; 110(9):1328-1331. PMC: 7427233. DOI: 10.2105/AJPH.2020.305782. View